At-home molecular testing
|
| Post date: 2024-11-13 04:45:03 |
| Views: 60 |
I seem to remember someone here recommending a tabletop at-home device for Covid testing (maybe NAAT?) that's approved in the European market but not in the US. Can someone here remind me?
Context: We've got an ambiguous rapid antigen test result for COVID in our house. The line is so faint that it is not pink or red, although two out of three of us see something there, like a shadow. We'd hoped to confirm with PCR so we can plan (eg what are the chances we'll need to cancel our Thanksgiving trip to see my elderly mother in her nursing home?) but we learned that molecular testing isn't offered in our region anymore.
I know that I might not be able to buy anything that is immediately useful for this situation, but since Covid isn't going anywhere, maybe this is worth an investment. We do plan to follow up with more RATs over the next few days.
We do know that CDC guidelines don't require us to care. I'm not worried for my kid at all, she's only mildly ill. I just want to do the right things to limit spread, here and in future. |
| Please click Here to read the full story. |
| |
| Other Top and Latest Questions: |
Trump administration equity stakes pose risks to U.S. companies and markets
|
Nearly a thousand Google workers sign letter urging company to divest from ICE, CBP
|
In reversal, Trump backs Nexstar's proposed acquisition of Tegna
|
The new Bilt 2.0 cards are open for application. Here's how to decide which card is right for you
|
Pressure mounts on American Airlines CEO as carrier lags rivals
|
Trump’s 'big beautiful bill' may spur significant changes to higher education in 2026 and the rise of 'un-college,' experts say
|
NFL plans to have discussions with partners outside of core media for live games, media chief says
|
Japanese Prime Minister Takaichi's ruling LDP set to secure supermajority in Lower House: NHK
|
Federal judge orders Fulton County Georgia election case documents unsealed by Tuesday
|
Japan's Nikkei 225 skyrockets over 5% to hit record highs as Takaichi secures historic mandate
|